DCN Monthly Series: New Anticancer Treatments 2022 (November)

The purpose of this offering is to discuss new anticancer treatments. By the end of this course, the learners should be able to review the pharmacology of newly approved anticancer agents, discuss literature supporting approval of new anticancer agents, identify clinical pearls for new anticancer agents, and evaluate place in therapy for newly approved anticancer agents.

Target Audience

  • MD
  • RN
  • Pharmacy
  • Pharmacy Tech
  • NP
  • PA

Learning Objectives

•        Review the pharmacology of newly approved anticancer agents

•        Discuss literature supporting approval of new anticancer agents

•        Identify clinical pearls for new anticancer agents

•        Evaluate place in therapy for newly approved anticancer agents

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
12/26/2022
Registration Expires: 
12/26/2024
Rating: 
0
  • AMA
  • ACPE
  • ANCC
  • JA-AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.